Radiotherapy prior to surgery reduces risk of secondary tumours in early-stage breast cancer

Moffitt Cancer Centre researchers launched a first of its kind study comparing the long-term benefits of radiation therapy in women with breast cancer either before surgery (neoadjuvant) or after surgery (adjuvant). Their study, published in the June 30 issue of Breast Cancer Research, found that patients who have neoadjuvant radiotherapy have a significantly lower risk of developing a second primary tumour at any site.